TP
Insider selling
Terrance P. Coyne sold $1.7M of Royalty Pharma plc (RPRX) stock
Terrance P. Coyne, EVP & CFO of Royalty Pharma plc (RPRX), sold 34,791 shares of RPRX stock worth $1.7M, per an SEC Form 4 filed Apr 30, 2026.
It was an open-market sale.
The trade happened on Apr 28, 2026, 2 days before it was made public.
RPRX has moved +18.0% since the trade date, from $49.54 to $58.44 (Sep 21, 2026 close).
- Traded
- Apr 28, 2026
- Disclosed
- Apr 30, 2026
- Filing delay
- 2 days
- Price since
- +18.0%
- Role
- EVP & CFO
- Source
- SEC Form 4
More RPRX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.